Cancer Topics

The On-Topic Netowork

Cancer > Animal Model


Animal Model
Animal Model
Animal Model
Animal Model
Animal Model

The following information is about Animal Model.

Animal Model Defined

An animal with a disease either the same as or like a disease in humans. Animal models are used to study the development and progression of diseases and to test new treatments before they are given to humans. Animals with transplanted human cancers or other tissues are called xenograft models.

This definition is in context to Cancer. See more contextual defintions for Animal Model.


Navigation: [ 1 2 Next ]

First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model

Published December 1, 2008, 12:10 pm, Medical News Today

Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure(1).

Full Story


Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors

Published December 1, 2008, 6:12 am, Medical News Today

A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches.

Full Story


Drug combo may help treat previously resistant tumours

Published December 1, 2008, 1:25 am, New Kerala

London, Dec 1 : A team of scientists has discovered a potential treatment for a group of tumours that have resisted previous targeted therapy approaches.

Full Story


Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors

Published November 30, 2008, 2:25 pm, Science Daily

Cancer researchers have discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. They found that blocking 2 cell signaling pathways leads to a dramatic shrinkage of K-Ras-mutated tumors in an animal model.

Full Story


Combining targeted therapy drugs may treat previously resistant tumors

Published November 30, 2008, 10:27 am, EurekAlert!

( Massachusetts General Hospital ) A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. In their Nature Medicine report, receiving early online release, the investigators report that combining two different kinase inhibitors -- drugs that interfere with ...

Full Story


Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ...

Published November 30, 2008, 10:21 am, Finanzen.net

Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and ...

Full Story


Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ...

Published November 30, 2008, 10:16 am, Centre Daily Times

Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure (1) . The new findings demonstrated that miR-21 ...

Full Story


Cancer linked specific protein's inactivation halts prostate tumour progression in animal model: USC

Published November 29, 2008, 2:50 am, PharmaBiz

University of South California (USC) researchers have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

Full Story


Pharmacyclics Announces Completion Of Phase 1 Clinical Trial Of Factor VIIa Inhibitor PCI-27483

Published November 26, 2008, 3:11 am, Medical News Today

Pharmacyclics, Inc. (Nasdaq: PCYC) announced that the company has completed a Phase 1 clinical trial with PCI-27483, the company's novel, first-in-class small-molecule Factor VIIa inhibitor. The trial was conducted in sixteen (16) healthy volunteers to evaluate the safety and pharmacologic effect of PCI-27483.

Full Story


USC Researchers Identify Novel Approach For Suppressing Prostate Cancer Development

Published November 25, 2008, 5:13 am, Medical News Today

Inactivation of a specific protein associated with cancer development halts prostate tumor progression in animal model Los Angeles, Calif. Nov. 24, 2008 California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Cancer > Animal Model news? Try our new "Animal Model News Focus" area.

Off-site Animal Model Links, User Submitted

The following links have been collected through user bookmark submission in the Animal Model category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Sat Nov 8

  • WARNING - Parkinson's, Epidemiologica l and animal model studies, Mitochondrial dysfunction - Emory University, Atlanta, Georgia, Parkinson's Institute, Sunnyvale, California - 2006: Parkinson' ;s disease (PD) is a progressive neurological disorder marked by nigrostriatal dopaminergic degeneration and development of cytoplasmic proteinaceous aggregates known as Lewy bodies. Although the pathogenic mechanisms responsible for PD are not completely understood, many clues have come from biochemical, epidemiologica l, and genetic studies. Mutations in certain genes found in rare, familial cases of PD, such as ?-synuclein and parkin, suggest a role for the ubiquitin-prot eosome system and aberrant protein aggregation. Biochemical analyses have implicated mitochondrial dysfunction in PD. Epidemiologica l and animal model studies point to a role for environmental toxins, some of which are mitochondrial inhibitors. Mitochondrial dysfunction, resulting from either genetic defects, environmental exposures or an interaction between the two, may cause ?-synuclein aggregation or neurodegenerat ion through oxidative stress or excitotoxicity .

Tue Sep 16

Mon Sep 15

Fri Sep 5

Sun Aug 10

Thu May 29

Tue May 20

Wed Mar 12

Wed Jan 30

Tue Jan 29

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Animal Model. If you would like to find related tags we recommend Tag Patterns > Animal Model

Off-site Animal Model Research Links

If you still need additional information on Animal Model then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cancer

If you know the Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a